PI
-
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
PETRA consortium, 22 Jun 2023, In: Blood. 141, 25, p. 3055-3064 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
Verhoeff, S. R., Oosting, S. F., Elias, S. G., van Es, S. C., Gerritse, S. L., Angus, L., Heskamp, S., Desar, I. M. E., Menke-van der Houven van Oordt, C. W., van der Veldt, A. A. M., Arens, A. I. J., Brouwers, A. H., Eisses, B., Mulders, P. F. A., Hoekstra, O. S., Zwezerijnen, G. J. C., van der Graaf, W. T. A., Aarntzen, E. H. J. G., Oyen, W. J. G. & van Herpen, C. M. L., 1 Feb 2023, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 29, 3, p. 592-601 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
On behalf of the PETRA Consortium, 24 Jan 2023, In: Blood advances. 7, 2, p. 214-223 10 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications